公司資料
Galapagos NV 股價、新聞與催化劑
- 股票代碼:
- GLPG
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- Belgium
股票表現
27.73 USD (-3.75%)
收盤價
最後更新: 2026年5月7日
1.83B USD
市值
股價為何變動
Current closing-price context is not available for GLPG.
公司概覽
業務概覽
Galapagos is a biotechnology company with a long history in immunology and inflammatory disease, and it has also redefined itself around partnership and pipeline strategy. Its story is shaped by platform science, corporate evolution, and a global footprint.
所在地與產業分類
Galapagos is headquartered in Belgium and listed on NASDAQ. It sits in global specialty biotechnology.
商業模式特徵
The company depends on pipeline progress, partnership strategy, and the ability to convert its scientific base into durable value. Investors watch clinical updates, business development, and portfolio direction.
生技產業定位
Galapagos occupies a global immunology-biotech niche. The stock is driven by whether the company can keep its innovation engine relevant after strategic shifts.
未來催化劑
- Galapagos’s catalysts are oncology and cell-therapy repositioning, plus any update that clarifies how much value remains in the post-reshape platform. The market will care more about strategic direction than about broad pipeline optionality.
近期新聞
- 01
- 02
- 03
- 04
- 05
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。